Main Session
Sep
29
SS 36 - Predicting Benefit and Toxicity: Biomarkers in Prostate Radiotherapy
311 - Germline Biomarker for Late Genitourinary Adverse Events after Radiotherapy for Prostate Cancer: Validation in Multiple Prospective Trials
Presenter(s)
Amar Kishan, MD - UCLA, Culver City, California